Cargando…
Sickle Cell Disease and Venous Thromboembolism
Hemoglobin S in homozygous state or in combination with one of the structural variants of Hb D-Punjab, Hb O-Arab, Hb C or β-thalassemia mutation results in sickle cell disease (SCD) that is characterized by chronic hemolytic anemia and tissue injury secondary to vasooclusion. A chronic hypercoagulab...
Autores principales: | Rahimi, Zohreh, Parsian, Abbas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113276/ https://www.ncbi.nlm.nih.gov/pubmed/21713075 http://dx.doi.org/10.4084/MJHID.2011.024 |
Ejemplares similares
-
COVID-19 and venous thromboembolism risk in patients with sickle cell disease
por: Singh, Ashima, et al.
Publicado: (2022) -
Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
por: Noubiap, Jean Jacques, et al.
Publicado: (2018) -
Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report
por: Rozi, Waail, et al.
Publicado: (2021) -
Venous Thromboembolism Post-COVID-19 Among Individuals with Sickle Cell Disease
por: Singh, Ashima, et al.
Publicado: (2021) -
Predisposing Factors and Incidence of Venous Thromboembolism among Hospitalized Patients with Sickle Cell Disease
por: Ziyadah, Mohammed S., et al.
Publicado: (2023)